DeviceClearance

K231348

Substantially Equivalent

Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSF

Applicant
Roche Diagnostics
Product code
QSE
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Indianapolis, IN, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.